Provided by Tiger Trade Technology Pte. Ltd.

NovaBay Pharmaceuticals

1.45
+0.240019.83%
Post-market: 1.42-0.0293-2.02%19:57 EDT
Volume:5.59M
Turnover:9.00M
Market Cap:37.70M
PE:0.62
High:1.85
Open:1.23
Low:1.22
Close:1.21
52wk High:99.75
52wk Low:1.11
Shares:26.00M
Float Shares:996.96K
Volume Ratio:18.82
T/O Rate:560.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.33
EPS(LYR):-12.6737
ROE:-516.26%
ROA:-86.98%
PB:-14.05
PE(LYR):-0.11

Loading ...

NovaBay Pharmaceuticals announces resignation of CEO David Lazar and transfer of preferred stock to new investors

Reuters
·
Oct 10, 2025

BRIEF-NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing

Reuters
·
Oct 04, 2025

NovaBay files $200M mixed securities shelf

TIPRANKS
·
Oct 04, 2025

NovaBay Pharmaceuticals Inc. Announces Date for Annual Stockholders Meeting

Reuters
·
Sep 24, 2025

Press Release: NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

Dow Jones
·
Sep 19, 2025

NovaBay Pharmaceuticals Inc. Announces Date for 2025 Annual Stockholders Meeting

Reuters
·
Sep 11, 2025

Top Midday Gainers

MT Newswires Live
·
Aug 28, 2025

NovaBay Pharmaceuticals Declares Special Cash Dividend of $0.80 a Share, Payable Sept. 29 to Holders of Record Sept. 15

MT Newswires Live
·
Aug 27, 2025

David Lazar Reports 19.99% Stake in NovaBay Pharmaceuticals Inc as of August 19 - SEC Filing

THOMSON REUTERS
·
Aug 27, 2025

David Lazar Says Purchased NovaBay Pharmaceuticals Shares Based on Belief That Shares, When Purchased, "Undervalued"

THOMSON REUTERS
·
Aug 27, 2025

Press Release: NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share

Dow Jones
·
Aug 27, 2025

NovaBay Pharmaceuticals Inc - Expects to Declare Special Cash Dividend in Q3 2025

THOMSON REUTERS
·
Aug 20, 2025

NovaBay Pharmaceuticals Inc - David E. Lazar Appointed as NovaBay's CEO and Director

THOMSON REUTERS
·
Aug 20, 2025

Press Release: NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Dow Jones
·
Aug 20, 2025